Search
Citations & References (1)
Invitrogen™
dNTP Mix (2.5 mM)
Invitrogen 2.5 mM dNTP (2'-deoxynucleoside 5'-triphosphate) Mix consists of a solution of all four nucleotides, dATP, dCTP, dGTP, and dTTP,Read more
| Catalog Number | Quantity |
|---|---|
| R72501 | 1 mL |
Catalog number R72501
Price (KRW)
220,000
Online offer
Ends: 31-Dec-2025
258,000Save 38,000 (15%)
Each
Quantity:
1 mL
Price (KRW)
220,000
Online offer
Ends: 31-Dec-2025
258,000Save 38,000 (15%)
Each
Invitrogen 2.5 mM dNTP (2'-deoxynucleoside 5'-triphosphate) Mix consists of a solution of all four nucleotides, dATP, dCTP, dGTP, and dTTP, each at a concentration of 2.5 mM. It is supplied in purified water and neutralized to pH 8.0 with NaOH. 2.5 mM dNTP Mix is suitable for use in a wide variety of molecular applications.
Applications
• Traditional PCR
• Sequencing
• cDNA synthesis
• Nick translation
• TdT-tailing reactions
For Research Use Only. Not for use in diagnostic procedures.
Specifications
Quantity1 mL
Shipping ConditionDry Ice
Concentration2.5 mM
For Use With (Application)Standard PCR
FormLiquid
Label or DyeUnlabeled
Unit SizeEach
Contents & Storage
dNTP Mix, 2.5 mM (2 x 500 μL)
Store at –20°C.
Store at –20°C.
Citations & References (1)
Citations & References
Abstract
Molecular emergence of acute myeloid leukemia during treatment for acute lymphoblastic leukemia.
Journal:Proc Natl Acad Sci U S A
PubMed ID:11526240
Therapy-related acute myeloid leukemias (t-AML) with translocations of the MLL gene are associated with the use of topoisomerase II inhibitors. We established the emergence of the malignant clone in a child who developed t-AML with a t(11;19) (q23;p13.3) during treatment for acute lymphoblastic leukemia (ALL). The MLL-ENL and the reciprocal